These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 10803505)
1. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma. Drexler HG; Matsuo Y Leukemia; 2000 May; 14(5):777-82. PubMed ID: 10803505 [TBL] [Abstract][Full Text] [Related]
2. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Yagita M; Huang CL; Umehara H; Matsuo Y; Tabata R; Miyake M; Konaka Y; Takatsuki K Leukemia; 2000 May; 14(5):922-30. PubMed ID: 10803526 [TBL] [Abstract][Full Text] [Related]
3. Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma. Matsuo Y; Drexler HG Leuk Res; 2003 Oct; 27(10):935-45. PubMed ID: 12860014 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection. Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726 [TBL] [Abstract][Full Text] [Related]
5. Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus. Kagami Y; Nakamura S; Suzuki R; Iida S; Yatabe Y; Okada Y; Kobayashi T; Tsurumi T; Seto M; Ogura M; Taguchi O; Morishima Y Br J Haematol; 1998 Dec; 103(3):669-77. PubMed ID: 9858215 [TBL] [Abstract][Full Text] [Related]
6. Aggressive variant of morphologically typical T large granular lymphocyte leukemia/lymphoma lacking NK cell markers. Passetto Falcão R; Pinto Simões B; Garcia AB; Fonseca BA; Terra Filho J Acta Haematol; 2000; 104(2-3):110-4. PubMed ID: 11154985 [TBL] [Abstract][Full Text] [Related]
7. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies. Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295 [TBL] [Abstract][Full Text] [Related]